Search
  • Site Search
  • News
  • Product
  • Zhejiang Medical Technology Development Co., Ltd.

    2019 year
    11
    07 day
    Winhealth Pharma Group expands new cooperation in rare disease field

    'Hand in hand, combine research with applications', Winhealth Pharma Group expands new cooperation in rare disease field

    ——Founding congress for Working Committee of Medication for Rare Diseases of Chinese Pharmacists Association and Sub-forum on Medication for Rare Diseases held

     

     

    On November 1 to 3, 2019, the 11th Chinese Pharmacist Conference, with Winhealth Pharma Group as its strategic partner, was solemnly held in Tai'an, Shandong Province, the 'Hometown of Confucius and Mencius and Land of Etiquette'.

     

    Winhealth Pharma Group was brilliant at the conference and participated in many aspects of the conference. The following are the highlights of the sub-forum on medication for rare diseases.


    Winhealth Pharma Group expands new cooperation in rare disease field Winhealth Pharma Group expands new cooperation in rare disease field


    On the eve of the conference, the Working Committee of Medication for Rare Diseases of Chinese Pharmacist Association was officially founded, and Mr. Wang Wei, board chairman/president of Hongkong Winhealth Pharma Group Co., Ltd, was appointed as the vice chairman. The committee held its first working meeting on November 1 at Taishan Baosheng Hotel.

     

    At the first working meeting, Mr. Wang and the members actively offered ideas and suggestions and discussed the work direction and plans of the committee. The working meeting preliminarily determined the focus and direction of work of the committee, and defined the work tasks of the members so as to better serve the patients with rare diseases in China.

     

    On the evening of November 1, Winhealth Pharma Group held a dinner party featuring 'Night of Winhealth', attended by many guests, including Chen Xiaohong, former vice minister of the Ministry of Health.

     

    At the dinner party, Zhang Yaohua, chairman of Chinese Pharmacists Association, awarded Winhealth Pharma Group an honorary medal of 'Strategic Partner'. Mr. Wang said that we will also further cooperate in the field of rare disease drugs, make contributions to the treatment of rare diseases, and bring benefits to the patients with rare diseases in China.

     

    Winhealth Pharma Group expands new cooperation in rare disease field Winhealth Pharma Group expands new cooperation in rare disease field


    On the afternoon of November 2, the sub-forum on medication for rare diseases of Chinese Pharmacist Conference was officially held, featuring the theme of 'Hand in hand, combine research with applications'. Professor Song Hongmei served as the chairman of the conference, and Chairman Zhang Yaohua and Vice Chairman Yan Xiaowen of the Chinese Pharmacists Association attended to give instructions. After the opening ceremony, the academic lectures of the sub-forum on medication for rare diseases officially started, and Mr. Wang and Professor Song Hong Mei co-chaired the second half of the conference.

     

    At the invitation of Winhealth Pharma Group,Professor Takashi Asada from Gifu University in Japan gave an introduction to the current status, research and development of medication for rare diseases in Japan. Professor Li Dingguo from Xinhua Hospital Affiliated to Shanghai Jiaotong University, who is vice chairman of China Rare Diseases Alliance and chairman of Rare Disease Prevention and Treatment Foundation of Shanghai, gave a description of the current situation and development trend of rare diseases, rare disease patients and drugs in an all-round way from the international and domestic perspectives, from the past to the present, from policy and legislation to non-governmental media publicity, and from research and development to applications. Professor Wu Wei and Professor Ju Xiuli gave reports on the problems in the application of growth hormone of some rare diseases, and the diagnosis and treatment status of rare diseases in the blood system respectively.

     

    The satellite meetings were also brilliant, and respectively described the drug reevaluation for TUDCA (Taurolite), and the gene diagnosis network construction and the multi-center research blueprint of pharmacogenomics, which are closely related to the diagnosis of rare diseases.


    Winhealth Pharma Group expands new cooperation in rare disease field Winhealth Pharma Group expands new cooperation in rare disease field


    This conference attracted the attention of all parties. More than 200 people attended the sub-forum, which was the largest sub-forum venue in this conference, indicating that rare diseases are gradually drawing people's attention, and that more doctors, pharmacists and people from all sides are working together to bring benefits to patients with rare diseases.

     

    It is believed that under the favorable policies of the State, Winhealth Pharma Group will also work together with the Committee of Medication for Rare Diseases, so that drugs are available and affordable to more patients with rare diseases to help them get cured.


    About Hong Kong Winhealth Pharma Group

    Founded in Hangzhou in 2006 and headquartered in Hong Kong, China, Winhealth Pharma Group is a one-stop professional service platform focusing on the whole process from drug registration submission, product import, market access, commercialization and life cycle management.


    As a new pharmaceutical enterprise promoting the development of China pharmaceuticals and health industry, Winhealth Pharma Group is dedicated to introducing world-leading health products and medical technologies into the China market, providing more excellent therapies and medical information dissemination channels for medical workers and more treatment and rehabilitation resources for patients, and creating a leading full-cycle, integrated and customized market access solution supplier and CDCO (contract development and commercialization organization, a commercialization service platform).


    Please visit the official website of Hong Kong Winhealth Pharma Group for more information: http://www.winhealth.hk/

    3rd Floor, Winhealth Industrial Park, No. 272 Huancheng East Road, Xiacheng District, Hangzhou, Zhejiang, China
    BD@winhealth.Hk (overseas)
    0571-8718 6358    4008393773 ( Product Hotline )
    Copyright ©2019 - 2024 Zhejiang Medical Technology Development Co., Ltd.